Siegfried Trattnig

With 7T MR the increase in signal to noise ratio, the higher BOLD contrast and higher spectral resolution offer additional benefits in the evaluation of brain cortex lesions and the hippocampal subfields and improved presurgical fMRI. High resolution spectroscopic imaging at 7T becomes feasible for tumors and MS. Sodium imaging provides noninvasive quantitative information of cartilage transplant quality. 31P MRS at 7T can differentiate between benign fatty liver disease and NASH. An additional clinical value of PET/MRI in terms of changes in management in up to 16% of cancer patients compared to PET/CT has been reported

Peter Jezzard

The recent emphasis on value in medical imaging, and the ever greater strain on many nations’ healthcare budgets as their population ages, has focused attention on what MRI and other similarly expensive imaging technologies can deliver. This extends to scientific advances, where grant funding bodies need to be persuaded that limited money spent on expensive technologies will lead to important scientific insights. The talk overviews a number of areas where high-end MRI seeks to make concrete scientific contributions.

Clare Tempany-Afdhal

MR imaging of the prostate has been performed in clinical practice for over 30 years. Recent years have seen very significant growth in prostate MR volume (Est 22% increase in 2017). MR guided interventions have been an option in clinical practice for over 20 years.  So, over the past 3O years multiple advances have converged to change the prostate cancer diagnosis and treatment paradigms and now there are new exciting approaches rapidly being adopted and deployed world-wide. Earlier this year this culminated in the PRECISION trial- an exciting multi-center randomized control trial of mpMRI vs TRUS guided prostate biopsies.